HK1205696A1 - 用於微生物感染的局部治療的組合物 - Google Patents
用於微生物感染的局部治療的組合物Info
- Publication number
- HK1205696A1 HK1205696A1 HK15106385.3A HK15106385A HK1205696A1 HK 1205696 A1 HK1205696 A1 HK 1205696A1 HK 15106385 A HK15106385 A HK 15106385A HK 1205696 A1 HK1205696 A1 HK 1205696A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compositions
- topical treatment
- microbial infections
- infections
- microbial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261636203P | 2012-04-20 | 2012-04-20 | |
US201261650755P | 2012-05-23 | 2012-05-23 | |
PCT/US2013/037430 WO2013159029A1 (en) | 2012-04-20 | 2013-04-19 | Compositions for topical treatment of microbial infections |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1205696A1 true HK1205696A1 (zh) | 2015-12-24 |
Family
ID=49380685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15106385.3A HK1205696A1 (zh) | 2012-04-20 | 2015-07-06 | 用於微生物感染的局部治療的組合物 |
Country Status (14)
Country | Link |
---|---|
US (3) | US9724295B2 (zh) |
EP (2) | EP4241844A3 (zh) |
JP (1) | JP6353437B2 (zh) |
KR (1) | KR20150008086A (zh) |
CN (1) | CN104363904A (zh) |
AU (1) | AU2013249086A1 (zh) |
BR (1) | BR112014026058A2 (zh) |
CA (1) | CA2870674C (zh) |
ES (1) | ES2958621T3 (zh) |
HK (1) | HK1205696A1 (zh) |
IL (1) | IL235130A0 (zh) |
IN (1) | IN2014DN08810A (zh) |
MX (1) | MX2014012676A (zh) |
WO (1) | WO2013159029A1 (zh) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005047475A2 (en) * | 2003-11-11 | 2005-05-26 | Regents Of The University Of Minnesota | Regulation of cell membrane-mediated effects |
EP4241844A3 (en) * | 2012-04-20 | 2023-11-08 | Hennepin Life Sciences | Compositions for topical treatment of microbial infections |
WO2015120310A1 (en) * | 2014-02-07 | 2015-08-13 | University Of Iowa Research Foundation | Method for decolonization of staphylococcus aureus |
US10786477B2 (en) | 2014-10-16 | 2020-09-29 | Natureza, Inc. | Formulations having anti-inflammatory activity and antimicrobial activity against gram-positive bacteria |
CA2995816A1 (en) * | 2015-08-19 | 2017-02-23 | Hennepin Life Sciences, Llc | Compositions and methods to treat infected ear conditions |
EP3362062A4 (en) * | 2015-10-14 | 2019-08-28 | Hennepin Life Sciences, LLC | COMPOSITIONS AND METHOD FOR THE TREATMENT OF HARVESIS OF INJURY |
CA3030408A1 (en) * | 2016-07-11 | 2018-01-18 | Hennepin Life Sciences, Llc | Compositions for sexually transmitted diseases |
CN109200063A (zh) * | 2017-06-29 | 2019-01-15 | 中山大学 | 脆弱拟杆菌在制备用于治疗和预防结核病的药物中的应用 |
WO2019033125A1 (en) * | 2017-08-11 | 2019-02-14 | Natureza, Inc. | LAURIC ACID DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST GRAM POSITIVE AND / OR NEGATIVE GRAM ORGANISMS |
WO2019079150A1 (en) * | 2017-10-18 | 2019-04-25 | Hennepin Life Sciences, Llc | COMPOSITIONS AND METHODS FOR TREATING ATOPIC DERMATITIS |
US20220047615A1 (en) * | 2018-11-30 | 2022-02-17 | Locus Ip Company, Llc | Immune Supplement Composition |
US20220015406A1 (en) * | 2019-01-25 | 2022-01-20 | Flaask, Llc | Compositions and Methods for Improving Quality of Life in Patients with Autism Spectrum Disorder |
FR3093650B1 (fr) | 2019-03-11 | 2022-12-30 | Id4Feed | Nouveau solvant d’extraction, de solubilisation et/ou de formulation de composés volatiles et non-volatiles d’intérêt en alimentation et santé animale, procédé de préparation et utilisations associées |
GB201906653D0 (en) * | 2019-05-10 | 2019-06-26 | Cc Biotech Ltd | Polypeptides for treatment of bacterial infections |
CN111759852A (zh) * | 2020-08-04 | 2020-10-13 | 驯鹿(北京)管理咨询有限公司 | 一种***用药物组合物及其药物制剂、制备方法和用途 |
WO2022046668A1 (en) * | 2020-08-22 | 2022-03-03 | Luc Montagnier | Compositions and methods for reducing the transmissivity of illnesses |
US11572342B2 (en) | 2020-09-18 | 2023-02-07 | Niche Biopharmaceuticals LLC | Antimicrobial and antiviral sulfur containing glycerol monoester derivatives |
AU2022280030A1 (en) * | 2021-05-26 | 2023-12-14 | Hennepin Life Sciences, Llc | Composition for topical treatment of microbial infections |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5208257A (en) * | 1986-04-21 | 1993-05-04 | Kabara Jon J | Topical antimicrobial pharmaceutical compositions and methods |
CA1302280C (en) * | 1986-04-21 | 1992-06-02 | Jon Joseph Kabara | Topical antimicrobial pharmaceutical compositions and methods |
US4746515A (en) * | 1987-02-26 | 1988-05-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolaurate |
US5260053A (en) * | 1991-12-30 | 1993-11-09 | Tom's Of Maine | Herbal deodorant |
US5256405A (en) * | 1991-12-30 | 1993-10-26 | Tom's Of Maine | Herbal deodorant |
EP0760650B1 (en) * | 1994-05-20 | 2002-07-31 | Novavax, Inc. | Antimicrobial oil-in-water emulsions |
US5569461A (en) | 1995-02-07 | 1996-10-29 | Minnesota Mining And Manufacturing Company | Topical antimicrobial composition and method |
US5906814A (en) * | 1995-12-07 | 1999-05-25 | The Andrew Jergens Company | Topical film-forming compositions |
US6645506B1 (en) * | 1997-04-18 | 2003-11-11 | Ganeden Biotech, Inc. | Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil |
US20020031556A1 (en) * | 2000-07-21 | 2002-03-14 | Lindahl Ake R. | Stabilized hydrogen peroxide composition and method of making a stabilized hydrogen peroxide composition |
US20050058673A1 (en) * | 2003-09-09 | 2005-03-17 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
WO2005047475A2 (en) | 2003-11-11 | 2005-05-26 | Regents Of The University Of Minnesota | Regulation of cell membrane-mediated effects |
US8796332B2 (en) * | 2004-08-03 | 2014-08-05 | Regents Of The University Of Minnesota | Compositions and methods for controlling infections |
EP1799266A2 (en) * | 2004-09-13 | 2007-06-27 | Bharat Serums & Vaccines Ltd. | Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy |
ATE420625T1 (de) * | 2005-08-05 | 2009-01-15 | Bharat Serums & Vaccines Ltd | Intravenöse propofol-emulsionszusammensetzungen mit konservierendem effekt |
MY140578A (en) * | 2005-12-07 | 2009-12-31 | Malaysian Agricultural Res And Dev Inst Mardi | Modified coconut oils with broad antimicrobial spectrum |
JP5575788B2 (ja) * | 2008-11-21 | 2014-08-20 | マクニール−ピーピーシー・インコーポレーテツド | 人体の表面に接触して使用される製造物品用のコーティング組成物及びコーティングされた基材 |
WO2011035158A2 (en) * | 2009-09-17 | 2011-03-24 | Guthery B Eugene | Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria |
EP4241844A3 (en) | 2012-04-20 | 2023-11-08 | Hennepin Life Sciences | Compositions for topical treatment of microbial infections |
US10579108B2 (en) | 2016-03-20 | 2020-03-03 | Case Cam LLC | Phone case with camera |
-
2013
- 2013-04-19 EP EP23183459.9A patent/EP4241844A3/en active Pending
- 2013-04-19 US US13/866,722 patent/US9724295B2/en active Active
- 2013-04-19 MX MX2014012676A patent/MX2014012676A/es unknown
- 2013-04-19 CN CN201380023979.8A patent/CN104363904A/zh active Pending
- 2013-04-19 EP EP13778577.0A patent/EP2838524B1/en active Active
- 2013-04-19 KR KR1020147031055A patent/KR20150008086A/ko not_active Application Discontinuation
- 2013-04-19 AU AU2013249086A patent/AU2013249086A1/en not_active Abandoned
- 2013-04-19 ES ES13778577T patent/ES2958621T3/es active Active
- 2013-04-19 CA CA2870674A patent/CA2870674C/en active Active
- 2013-04-19 JP JP2015507227A patent/JP6353437B2/ja active Active
- 2013-04-19 WO PCT/US2013/037430 patent/WO2013159029A1/en active Application Filing
- 2013-04-19 BR BR112014026058A patent/BR112014026058A2/pt not_active IP Right Cessation
-
2014
- 2014-10-19 IL IL235130A patent/IL235130A0/en unknown
- 2014-10-20 IN IN8810DEN2014 patent/IN2014DN08810A/en unknown
-
2015
- 2015-07-06 HK HK15106385.3A patent/HK1205696A1/zh unknown
-
2016
- 2016-02-29 US US15/056,239 patent/US11786454B2/en active Active
-
2017
- 2017-10-09 US US15/727,772 patent/US20180092835A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20130281532A1 (en) | 2013-10-24 |
US9724295B2 (en) | 2017-08-08 |
EP4241844A3 (en) | 2023-11-08 |
EP2838524B1 (en) | 2023-07-05 |
WO2013159029A1 (en) | 2013-10-24 |
IN2014DN08810A (zh) | 2015-05-22 |
US20160175244A1 (en) | 2016-06-23 |
EP2838524A4 (en) | 2015-12-30 |
ES2958621T3 (es) | 2024-02-12 |
JP2015514782A (ja) | 2015-05-21 |
AU2013249086A1 (en) | 2014-10-30 |
CN104363904A (zh) | 2015-02-18 |
EP4241844A2 (en) | 2023-09-13 |
JP6353437B2 (ja) | 2018-07-04 |
IL235130A0 (en) | 2014-12-31 |
KR20150008086A (ko) | 2015-01-21 |
US20180092835A1 (en) | 2018-04-05 |
BR112014026058A2 (pt) | 2017-06-27 |
EP2838524A1 (en) | 2015-02-25 |
CA2870674C (en) | 2022-05-03 |
MX2014012676A (es) | 2015-06-22 |
CA2870674A1 (en) | 2013-10-24 |
US11786454B2 (en) | 2023-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1205696A1 (zh) | 用於微生物感染的局部治療的組合物 | |
HK1216389A1 (zh) | 治療局部微生物感染的方法 | |
HK1209755A1 (zh) | 用於治療細菌感染的甘露糖衍生物 | |
HK1203361A1 (zh) | 用於治療真菌感染的局部油組合物 | |
PL2696890T3 (pl) | Leczenie infekcji drobnoustrojowych | |
PT2694021E (pt) | Composição cicatrizante para aplicação tópica | |
GB201217097D0 (en) | Treatment of bacterial infection | |
IL237035B (en) | Antibacterial compound for external use | |
EP2897613A4 (en) | TREATMENT COMPOSITIONS | |
HRP20160150T1 (en) | Treatment of streptococcal infections | |
RS58837B1 (sr) | Farmaceutska kompozicija za tretiranje hiv infekcija | |
EP2844258A4 (en) | METHOD AND COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS | |
EP2916653A4 (en) | ANTIBIOTIC METHODS AND ANTIBIOTIC COMPOSITIONS FOR BACTERIAL INFECTIONS | |
PL2617412T3 (pl) | Kompozycja do leczenia miejscowego | |
ZA201308116B (en) | Avian-based treatment for microbial infections | |
PL2431030T3 (pl) | Leczenie infekcji grzybiczych | |
EP2529728A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS | |
HK1206633A1 (zh) | 用於疣的治療的組合物 | |
EP2670407A4 (en) | TREATMENT OF BACTERIAL INFECTIONS | |
EP2685820A4 (en) | COMPOSITIONS AND METHODS FOR TREATING INFECTIONS | |
GB201212715D0 (en) | Treatment of fungal infections | |
GB201204364D0 (en) | Topical treatment of wounds |